Applied DNA Sciences shares are trading lower after the company announced the pricing of a $12 million public offering.
Portfolio Pulse from Benzinga Newsdesk
Applied DNA Sciences shares are trading lower following the announcement of a $12 million public offering.
May 28, 2024 | 2:26 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied DNA Sciences shares are trading lower after the company announced the pricing of a $12 million public offering.
The announcement of a public offering often leads to a decrease in share price due to potential dilution of existing shares. Investors may be concerned about the impact on their holdings.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100